UPC vs. INTC

Last updated Apr 1, 2026

Compare and contrast key facts about Universe Pharmaceuticals INC (UPC) and Intel Corporation (INTC).

Performance

UPC vs. INTC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Universe Pharmaceuticals INC (UPC) and Intel Corporation (INTC). The values are adjusted to include any dividend payments, if applicable.

UPC vs. INTC - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
UPC Universe Pharmaceuticals INC	-27.82%	-84.39%	-97.98%	-76.90%	-11.31%	-65.58%
INTC Intel Corporation	19.59%	84.04%	-59.57%	94.56%	-46.64%	-17.27%

Fundamentals

EPS UPC : -$22.01 INTC : -$0.06
PS Ratio UPC : 0.04 INTC : 3.72
Total Revenue (TTM) UPC : $40.88M INTC : $52.85B
Gross Profit (TTM) UPC : $12.37M INTC : $18.48B
EBITDA (TTM) UPC : -$10.28M INTC : $11.19B

Returns By Period

In the year-to-date period, UPC achieves a -27.82% return, which is significantly lower than INTC's 19.59% return.

UPC

• 1D: 4.96%
• 1M: 1.10%
• YTD: -27.82%
• 6M: -34.52%
• 1Y: -32.93%
• 3Y*: -89.05%
• 5Y*: -82.92%
• 10Y*: —

INTC

• 1D: 7.14%
• 1M: -3.24%
• YTD: 19.59%
• 6M: 31.54%
• 1Y: 94.32%
• 3Y*: 11.44%
• 5Y*: -5.55%
• 10Y*: 5.48%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

UPC vs. INTC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

UPC

UPC Risk / Return Rank: 35
UPC Sharpe Ratio Rank: 32
UPC Sortino Ratio Rank: 48
UPC Omega Ratio Rank: 47
UPC Calmar Ratio Rank: 23
UPC Martin Ratio Rank: 26

INTC

INTC Risk / Return Rank: 85
INTC Sharpe Ratio Rank: 84
INTC Sortino Ratio Rank: 83
INTC Omega Ratio Rank: 80
INTC Calmar Ratio Rank: 91
INTC Martin Ratio Rank: 88

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

UPC vs. INTC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Universe Pharmaceuticals INC (UPC) and Intel Corporation (INTC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	UPC	INTC	Difference
Sharpe ratio Return per unit of total volatility	-0.22	1.43	-1.65
Sortino ratio Return per unit of downside risk	0.73	2.20	-1.47
Omega ratio Gain probability vs. loss probability	1.09	1.27	-0.18
Calmar ratio Return relative to maximum drawdown	-0.57	3.90	-4.48
Martin ratio Return relative to average drawdown	-0.91	8.83	-9.75
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

UPC vs. INTC - Sharpe Ratio Comparison

The current UPC Sharpe Ratio is -0.22, which is lower than the INTC Sharpe Ratio of 1.43. The chart below compares the historical Sharpe Ratios of UPC and INTC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	UPC	INTC	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.22	1.43	-1.65
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.49	-0.12	-0.37
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.13	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.48	0.31	-0.79

Correlation

The correlation between UPC and INTC is 0.05, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

UPC vs. INTC - Dividend Comparison

Neither UPC nor INTC has paid dividends to shareholders.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
UPC Universe Pharmaceuticals INC	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
INTC Intel Corporation	0.00%	0.00%	1.87%	1.47%	5.52%	2.70%	2.65%	2.11%	2.56%	2.33%	2.87%	2.79%

Drawdowns

UPC vs. INTC - Drawdown Comparison

The maximum UPC drawdown since its inception was -99.99%, which is greater than INTC's maximum drawdown of -82.25%. Use the drawdown chart below to compare losses from any high point for UPC and INTC.

Drawdown Indicators

	UPC	INTC	Difference
Max Drawdown Largest peak-to-trough decline	-99.99%	-82.25%	-17.74%
Max Drawdown (1Y) Largest decline over 1 year	-76.24%	-24.17%	-52.07%
Max Drawdown (5Y) Largest decline over 5 years	-99.99%	-70.80%	-29.19%
Max Drawdown (10Y) Largest decline over 10 years	—	-70.80%	—
Current Drawdown Current decline from peak	-99.99%	-28.92%	-71.07%
Average Drawdown Average peak-to-trough decline	-85.78%	-36.79%	-48.99%
Ulcer Index Depth and duration of drawdowns from previous peaks	47.92%	10.68%	+37.24%

Volatility

UPC vs. INTC - Volatility Comparison

Universe Pharmaceuticals INC (UPC) has a higher volatility of 24.61% compared to Intel Corporation (INTC) at 20.06%. This indicates that UPC's price experiences larger fluctuations and is considered to be riskier than INTC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	UPC	INTC	Difference
Volatility (1M) Calculated over the trailing 1-month period	24.61%	20.06%	+4.55%
Volatility (6M) Calculated over the trailing 6-month period	98.87%	46.47%	+52.40%
Volatility (1Y) Calculated over the trailing 1-year period	151.63%	66.30%	+85.33%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	170.16%	48.33%	+121.83%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	171.03%	41.78%	+129.25%

Financials

UPC vs. INTC - Profitability Comparison

The chart below illustrates the profitability comparison between Universe Pharmaceuticals INC and Intel Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

UPC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Universe Pharmaceuticals INC reported a gross profit of 3.14M and revenue of 8.71M. Therefore, the gross margin over that period was 36.0%.

INTC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Intel Corporation reported a gross profit of 5.04B and revenue of 13.67B. Therefore, the gross margin over that period was 36.9%.

UPC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Universe Pharmaceuticals INC reported an operating income of -589.16K and revenue of 8.71M, resulting in an operating margin of -6.8%.

INTC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Intel Corporation reported an operating income of 667.00M and revenue of 13.67B, resulting in an operating margin of 4.9%.

UPC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Universe Pharmaceuticals INC reported a net income of -387.30K and revenue of 8.71M, resulting in a net margin of -4.5%.

INTC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Intel Corporation reported a net income of -591.00M and revenue of 13.67B, resulting in a net margin of -4.3%.